Uncovering global research frontiers in deubiquitinating enzymes and immunotherapy: A bibliometric study
Recently, immunotherapy has been a key therapeutic strategy for cancer. Deubiquitinating enzymes (DUBs), which are protein-modifying enzymes, have a crucial role in the pathogenesis of cancer, autoimmune diseases, and inflammation. DUBs influence the tumor immune microenvironment by regulating immun...
Saved in:
| Main Authors: | Xia Chen, Yang Qin, Jinfeng Gan, Tangwen Wei, Xinyi Wei, Yaling Xiong, Zhichang Zhang, Bing Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2483558 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of deubiquitinases in cardiovascular diseases: mechanisms and therapeutic implications
by: Xiangyu Fei, et al.
Published: (2025-05-01) -
USP8 protects rat-derived H9C2 cardiomyocytes from doxorubicin-triggered ferroptosis and cell death through deubiquitination-mediated stabilization of MDM4
by: Yixi Li, et al.
Published: (2025-08-01) -
USP5-induced deubiquitination of P4HB alleviates ER stress-mediated apoptosis in intestinal ischemia/reperfusion
by: Shili Ning, et al.
Published: (2025-06-01) -
Research hotspots and trends of immunotherapy and melanoma: A bibliometric analysis during 2014–2024
by: Zixuan Jia, et al.
Published: (2025-12-01) -
A bibliometric analysis of challenges and advancements in the integrated application of nanoparticles and chimeric antigen receptor T cell therapy
by: Yang Gao, et al.
Published: (2025-12-01)